Table 1 Baseline characteristics in the study groups

Age (years) [mean ± SD]

52.6 ± 12.1

54.8 ± 9.5

0.53^†

Gender [no. (%)]

 Male

48 (80)

48 (80)

1§

 Female

12 (20)

12 (20)

MELD score [mean ± SD]

14.5 ± 3.2

9.2 ± 2.9

0.001^†

Hemoglobin (g/dl) [mean ± SD]

9 ± 1.4

12 ± 2

< 0.001^†

Hematocrit (%) [mean ± SD]

27.5 ± 4.8

40.9 ± 6.5

< 0.001^†

Platelets (1 × 10³/µl) [median (IQR)]

72 (58.3–108.3)

115 (64.3–193)

0.03^‡

Total bilirubin (mg/dl) [mean ± SD]

2.5 ± 1.1

0.9 ± 0.3

< 0.001^†

ALT (IU/l) [median (IQR)]

79 (52.8–115)

22(17.3–30)

< 0.001^‡

AST (IU/l) [median (IQR)]

93 (46.8–180)

37.5 (23.3–41.5)

< 0.001^‡

Serum albumin (gm/dl) [mean ± SD]

2.9 ± 0.7

4 ± 0.6

< 0.001^†

INR [median (IQR)]

1.3 (1.2–1.6)

1.2 (1–1.5)

0.049^−‡

aPPT (s) [mean ± SD]

45 ± 15

37.9 ± 9.4

0.08^†

Serum creatinine (mg/dl) [mean ± SD]

1.1 ± 0.4

0.8 ± 0.2

0.008^†

PVD (mm) [mean ± SD]

14.8 ± 3.9

11 ± 1.4

< 0.001^†

PSV (cm/s) [mean ± SD]

12 ± 1.4

17 ± 5.3

< 0.001^†

Grade of EVs [no. (%)]

 0–II

3 (5)

60 (100)

< 0.001^¶

 III–IV

57 (95)

0 (0)